Structured intelligence on corporate strategy, market moves, and industry signals.
Each entry is a briefing, not a headline: event summary, strategic context, and what to watch next.
A Company Pulse is our reading of what a company says in its own press release, with the questions we would want answered. It is not verified reporting and it is not an endorsement. Pulses are made from press releases we collect from several sources, including Wire. Nobody can pay for a Pulse.
Lotus Technology Inc. received a $23 million investment from ECARX Holdings Inc. via a private placement of 16,788,321 ordinary shares at $1.37 per share.
ECARX is making a $23 million strategic investment in Lotus Technology through a private placement of 16.79 million ordinary shares at $1.37 per share.
Nevada King increased its Atlanta Gold Mine project’s measured and indicated resources by 122% to over 1 million ounces, grading 1.14 g/t Au, as of June 2025.
Alphamab Oncology received acceptance from the China National Medical Products Administration’s (NMPA) Center for Drug Evaluation (CDE) for a Phase II clinical study of JSKN033.
Can-Fite BioPharma has been granted Brazilian Patent No. BR112015002697-4 covering the use of its A3 adenosine receptor agonists for treating sexual dysfunction.
